Such a hybrid stage was described in human ovarian cancer cells freshly isolated from mouse xenografts, or, in situ, in human biopsies in which cancer cells simultaneously express the epithelial marker EpCAM and the mesenchymal marker vimentin [16]. The gene discussed is VIM; the disease is ovarian cancer.